BofA Securities Maintains Arvinas(ARVN.US) With Buy Rating, Raises Target Price to $57

Futu NewsDec 19 18:36 · Ratings

Analysts' Opinions Are Mixed on These Healthcare Stocks: Outset Medical (OM), Arvinas Holding Company (ARVN) and Innovent Biologics (OtherIVBXF)

TipRanksDec 19 18:30 · Ratings

Buy Rating for Arvinas Holding Company Driven by Vepdeg's Promising Potential and Market Opportunity

TipRanksDec 16 19:37 · Ratings

Barclays Maintains Arvinas(ARVN.US) With Buy Rating, Maintains Target Price $48

Futu NewsDec 13 16:32 · Ratings

Guggenheim Reiterates Buy on Arvinasto Buy

BenzingaDec 12 23:46

Evercore Initiates Arvinas(ARVN.US) With Buy Rating, Announces Target Price $110

Futu NewsDec 11 21:33 · Ratings